Thrombotic microangiopathy following a stem cell transplant is a rare but serious complication that often leads to progressive organ damage and death. Akari is working with urgency to develop bispecific (C5+LTB4) inhibitor #nomacopan for severe pediatric #HSCT-TMA.
